- Home
- DECK vs BNTX Comparison
DECK vs BNTX Comparison
Compare DECK & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DECK
- BNTX
- Stock Information
- Founded
- DECK 1973
- BNTX 2008
- Country
- DECK United States
- BNTX Germany
- Employees
- DECK N/A
- BNTX N/A
- Industry
- DECK Shoe Manufacturing
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DECK Consumer Discretionary
- BNTX Health Care
- Exchange
- DECK Nasdaq
- BNTX Nasdaq
- Market Cap
- DECK 30.8B
- BNTX 23.9B
- IPO Year
- DECK 1993
- BNTX 2019
- Fundamental
- Price
- DECK $208.01
- BNTX $114.13
- Analyst Decision
- DECK Buy
- BNTX Strong Buy
- Analyst Count
- DECK 21
- BNTX 15
- Target Price
- DECK $183.77
- BNTX $143.50
- AVG Volume (30 Days)
- DECK 1.7M
- BNTX 659.5K
- Earning Date
- DECK 01-30-2025
- BNTX 11-04-2024
- Dividend Yield
- DECK N/A
- BNTX N/A
- EPS Growth
- DECK 46.79
- BNTX N/A
- EPS
- DECK 5.68
- BNTX N/A
- Revenue
- DECK $4,656,732,000.00
- BNTX $3,390,698,192.00
- Revenue This Year
- DECK $16.54
- BNTX N/A
- Revenue Next Year
- DECK $10.89
- BNTX N/A
- P/E Ratio
- DECK $36.62
- BNTX N/A
- Revenue Growth
- DECK 19.25
- BNTX N/A
- 52 Week Low
- DECK $108.65
- BNTX $76.53
- 52 Week High
- DECK $214.70
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- DECK 62.90
- BNTX 49.15
- Support Level
- DECK $201.00
- BNTX $109.52
- Resistance Level
- DECK $214.70
- BNTX $115.34
- Average True Range (ATR)
- DECK 5.71
- BNTX 4.74
- MACD
- DECK -0.81
- BNTX -0.80
- Stochastic Oscillator
- DECK 65.23
- BNTX 29.03
About DECK Deckers Outdoor Corporation
Founded in 1973, California-based Deckers designs and sells casual and performance footwear, apparel, and accessories. In fiscal 2024, Ugg and Hoka accounted for 52% and 42% of total sales, respectively. The firm also markets niche brands Teva, Ahnu, and Koolaburra. Deckers generates most of its sales through wholesale partnerships, but also operates e-commerce in more than 50 countries and about 178 company-operated stores. The company generated 67% of its fiscal 2024 sales in the United States.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.